Health and Pharmaceuticals

Wesfarmers makes Healthscope inquiries

Wesfarmers doing ground work on merits of a $5bn bid for Healthscope.

Analysts warn on Wesfarmers' Healthscope bid

Analysts say lack of expertise may stifle Wesfarmers' Healthscope bid.

ResMed lifts Q3 earnings

by AAP
Medical technology group reports strong performances in Europe, Asia-Pacific.

Ramsay founder admitted to hospital

Board advises Paul Ramsay admitted to hospital in Europe 'in a serious condition'.

Wesfarmers weighs Healthscope bid

WA group considers bidding for hospital operator as deadline nears: report.

P and G sales dip slightly

by AFP
Consumer products giant sees largely flat sales, profit in Q1.

QRxPharma shares plummet 80%

Pharmaceutical group shares plunge after US FDA declines to approve its Moxduo product.

DataRoom AM: Healthscope scope-out

Several offshore suitors look to be interested in acquiring Healthscope, while BG Group gears up for a major infrastructure sell-off.

Novartis, GSK reveal huge deals

by AFP
Pharmaceutical giants announce major shake-ups worth over $20 billion.

Philips reports 15% profit slump

by AFP
Activities in healthcare equipment a drag on profit, numbers still top forecasts.

Kimberly-Clark reports Q1 profit lift

Kleenex maker reports steady earnings, falls short of expectations.

Japara shares up 34% on debut

Shares in the largest IPO to hit the boards this year surge on listing, after a bookbuild that was heavily oversubscribed.

API unveils $131m writedown

by AAP
Group says one-off impairment mainly related to changes in value of its loans to pharmacies.

API shares suspended

by AAP
Australian Pharmaceutical Industries to assess carrying value of its assets.

BlackBerry eyes healthcare niche

Ailing smartphone maker buys stake in healthcare IT firm NantHealth, whose platform already connects more than 16,000 medical devices.

Dutton hints at Medicare overhaul

1 comment
Health Minister calls for change, says healthcare spending trends ‘unsustainable’.

Credit Suisse, Goldman well placed for Medibank prize

The two investment banks hope a past mandate and their status as leading IPO underwriters in Australia will help them win a Medibank joint lead manager role.

API may lower distribution unit goodwill

Australian Pharmaceutical Industries may downwardly adjust the goodwill attached to its Australian Pharmacy distribution business as the industry battles new competition and regulatory change.

Cochlear chases Chinese sales

ASX-listed firm hoping to cash in on ageing Chinese population: report.

Japara restores IPO confidence

The residential aged care provider’s book build was brought forward 12 days and was two times over subscribed.